NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

Historical Holders from Q4 2015 to Q1 2025

Symbol
NVCR on Nasdaq
CUSIP
G6674U108
Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
110M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
91.5M
Holdings value
$2.73B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
239
Number of buys
107
Number of sells
-112
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 5% $118M 5.52M Soleus Capital Master Fund, L.P. Mar 31, 2025

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 319K $5.69M +$1.45M $17.82 27
2024 Q4 91.5M $2.73B -$6.28M $29.80 239
2024 Q3 92.9M $1.45B -$11.4M $15.63 220
2024 Q2 92.9M $1.59B +$79.8M $17.13 229
2024 Q1 89.1M $1.39B -$23.1M $15.63 230
2023 Q4 90.5M $1.35B -$20.8M $14.93 211
2023 Q3 91.2M $1.47B -$63.5M $16.15 215
2023 Q2 89.2M $3.7B -$22.4M $41.50 250
2023 Q1 89.3M $5.37B +$289M $60.14 285
2022 Q4 83.9M $6.15B -$13M $73.35 286
2022 Q3 83M $6.31B +$223M $75.98 284
2022 Q2 80M $5.56B -$38.8M $69.50 284
2022 Q1 81.1M $6.72B +$238M $82.85 287
2021 Q4 78.1M $5.87B +$31.1M $75.08 284
2021 Q3 77.5M $9B -$79.6M $116.17 300
2021 Q2 77.6M $17.2B +$682M $221.82 350
2021 Q1 73M $9.65B +$118M $132.18 313
2020 Q4 74.2M $12.8B +$247M $173.04 344
2020 Q3 73M $8.13B +$544M $111.31 265
2020 Q2 69.1M $4.1B -$79.7M $59.30 254
2020 Q1 70.2M $4.73B +$67.8M $67.34 255
2019 Q4 69M $5.82B +$164M $84.27 251
2019 Q3 66.7M $4.99B +$91.8M $74.78 230
2019 Q2 65.7M $4.15B +$248M $63.23 186
2019 Q1 63.5M $3.06B +$302M $48.17 193
2018 Q4 57.3M $1.92B +$53.7M $33.48 161
2018 Q3 54.7M $2.87B +$201M $52.40 172
2018 Q2 51.8M $1.62B +$283M $31.30 158
2018 Q1 44M $959M +$148M $21.80 131
2017 Q4 37.4M $755M +$13.4M $20.20 122
2017 Q3 36.8M $731M +$98.8M $19.85 101
2017 Q2 31.9M $551M +$204M $17.30 81
2017 Q1 20.2M $164M +$27.1M $8.10 66
2016 Q4 20.1M $158M +$10.1M $7.85 72
2016 Q3 18.8M $161M -$21.8M $8.54 61
2016 Q2 19.2M $224M +$67.2M $11.67 63
2016 Q1 13.6M $197M +$32.3M $14.48 55
2015 Q4 11.3M $249M +$249M $22.36 47